Compare ZBH & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZBH | FMS |
|---|---|---|
| Founded | 1927 | 1996 |
| Country | United States | Germany |
| Employees | N/A | 108165 |
| Industry | Industrial Specialties | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.0B | 13.0B |
| IPO Year | 2001 | N/A |
| Metric | ZBH | FMS |
|---|---|---|
| Price | $92.24 | $24.90 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 21 | 2 |
| Target Price | ★ $101.00 | $30.00 |
| AVG Volume (30 Days) | ★ 2.0M | 570.4K |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | 1.20% | ★ 2.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.22 | N/A |
| Revenue | ★ $8,231,500,000.00 | N/A |
| Revenue This Year | $4.96 | N/A |
| Revenue Next Year | $3.76 | $3.83 |
| P/E Ratio | $75.47 | ★ $15.62 |
| Revenue Growth | ★ 7.20 | N/A |
| 52 Week Low | $79.12 | $20.02 |
| 52 Week High | $108.29 | $27.64 |
| Indicator | ZBH | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 66.47 |
| Support Level | $85.21 | $22.47 |
| Resistance Level | $96.45 | $27.40 |
| Average True Range (ATR) | 2.58 | 0.31 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 69.62 | 95.03 |
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.